Table of Contents May 18, 2021; Volume Issue supplement 1 2021 SNMMI Annual Meeting Abstracts

  1. Abaei, Alireza

    1. Evaluation of the HET-CAM model for biodistribution studies of nanoparticles using PET and MR imaging
      Jessica Loeffler, Nina Eberhardt, Richard Fiedler, Markus Lau, Marco Raabe, Md Alam, Andrea Koch, Alireza Abaei, Hendrik Herrmann, Christoph Solbach, Tanja Weil, Mika Linden, Ambros Beer, Volker Rasche and Gordon Winter
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1246;

  2. Abascal Junquera, Jose Maria

    1. The SENSEI laparoscopic tethered gamma probe for sentinel lymph node biopsy in prostate cancer: initial experience from a multicenter clinical trial
      Jose Maria Abascal Junquera, Jochen Christoph Walz, Boris Hadaschik, Jim Adshead, Wouter Everaerts, Karolien Goffin, Maarten Ruben Grootendorst, Francesca Oldfield, Antoni Mestre Fusco, Sergi Vidal-Sicart and Lluis Fumado
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1007;

  3. Abayazeed, Aly

    1. Performance of the AdaptiSPECT-C system for tumor quantification, detection, and localization in123I-CLINDE brain SPECT imaging
      Benjamin Auer, Kesava Kalluri, Aly Abayazeed, Jan De Beenhouwer, Navid Zeraatkar, Matthew Kupinski, Phillip Kuo, Lars Furenlid and Michael King
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1400;

  4. Abbaszadeh, Shiva

    1. Electronic noise characterization of a dedicated head-and-neck cancer PET based on CZT
      Yuli Wang, Ryan Herbst and Shiva Abbaszadeh
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1154;

  5. Abbott, Amanda

    1. Two-years’ experience with a Zr-89 PET/CT scanner validation program for clinical trials
      John Sunderland, Amanda Abbott, Avital Weiss, Ian Wilson, William Le, Ronald Korn and Bonnie Clarke
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1399;
    2. Phase II, open label, multi-dose study of 89-Zr-Df-IAB22M2C (CD8 Immuno-PET Tracer): technical handling and injection instructions for optimal tracer administration.
      Kaylee Allred, Quinten Sanders, Monica Prince, Ron Korn, Ian Wilson, William Le, Avital Weiss, Amanda Abbott and David Hays
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 3004;

  6. Abd El-gaid, Salwa

    1. Percentage of reduction in FDG-PET/CT imaging biomarkers as a predictor for pathological response in breast cancer patients.
      Salwa Abd El-Gaid and Mai Elahmadawy
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1105;

  7. Abd Elaal, Asmaa

    1. Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?
      Asmaa Abd elaal, Ahmad Zaher, Marwa Khalifa, Mohamed Meckawy and Lamiaa Eloteify
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1097;

  8. Abdelhafez, Yasser

    1. Ultra-low-dose total-body 18F-FDG PET/CT in patients with autoimmune inflammatory arthritis: evaluation of image quality with shorter scan time
      Yasser Abdelhafez, Heather Hunt, Denise Caudle, Negar Omidvari, Benjamin Spencer, Lorenzo Nardo, Simon Cherry, Ramsey Badawi, Siba Raychaudhuri and Abhijit Chaudhari
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1697;
    2. Differences in Deauville scores generated using 60- and 120-minute uptake times on Total-Body 18F-FDG PET/CT scans
      Yasser Abdelhafez, Fatma Sen, Joseph Tuscano, Merin Stephen, Benjamin Spencer, Simon Cherry, Ramsey Badawi and Lorenzo Nardo
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1680;
    3. Blanching defects at the pressure points: a potential pitfall in dynamic Total-Body PET/CT studies
      Kristin McBride, Edwin Leung, Heather Hunt, Mike Nguyen, Benjamin Spencer, Simon Cherry, Ramsey Badawi, Lorenzo Nardo and Yasser Abdelhafez
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 186;
    4. Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR expression and overall survival
      Rehab Mostafa, Ahmed Kandeel, Maha Abdelkareem, Lorenzo Nardo and Yasser Abdelhafez
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1045;

  9. Abdelkareem, Maha

    1. Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR expression and overall survival
      Rehab Mostafa, Ahmed Kandeel, Maha Abdelkareem, Lorenzo Nardo and Yasser Abdelhafez
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1045;

  10. Abdelnaim, Aya

    1. Within-patient variability of18F-FDG uptake in normal tissues
      Mohamed Sayed, Aya Abdelnaim and Nsreen Mohamadien
      Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1588;
« Previous (Pages : 1 2 3 4 5 6 ... 372) Next »
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 18, 2021
Sign up for alerts